Details for Patent: 10,428,063
✉ Email this page to a colleague
Which drugs does patent 10,428,063 protect, and when does it expire?
Patent 10,428,063 protects HYRNUO and is included in one NDA.
This patent has thirty-six patent family members in thirty-one countries.
Summary for Patent: 10,428,063
| Title: | 4H-pyrrolo[3,2-C]pyridin-4-one derivatives |
| Abstract: | Compound of formula (I), processes for their production and their use as pharmaceuticals. |
| Inventor(s): | Keith Graham, Ulrich Klar, Hans Briem, Volker Schulze, Gerhard Siemeister, Philip Lienau, René TEMPEL, Jozsef BÁLINT |
| Assignee: | Bayer Pharma AG |
| Application Number: | US15/547,032 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent 10,428,063
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare | HYRNUO | sevabertinib | TABLET;ORAL | 219972-001 | Nov 19, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,428,063
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 103554 | ⤷ Start Trial | |||
| Australia | 2016212230 | ⤷ Start Trial | |||
| Brazil | 112017016193 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
